Mathers Edward T. - 02 Mar 2026 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Issuer symbol
RYTM
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 16:40:00 UTC
Previous filing
11 Feb 2026
Next filing
12 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mathers Edward T Director 104 5TH AVE, 19TH FLOOR, NEW YORK /s/ Zachary Bambach, attorney-in-fact 04 Mar 2026 0001328625

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Other +4,198 +73% $0.000000* 9,969 02 Mar 2026 See Note 2 F1, F2
holding RYTM Common Stock 7,000 02 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 NEA Partners 13, L.P. ("NEA Partners 13") made a pro rata distribution for no consideration of shares of Common Stock of the Issuer to its limited partners on March 2, 2026. The Edward Timothy Mathers Revocable Trust (the "Mathers Trust") received 4,198 shares of Common Stock of the Issuer in the distribution by NEA Partners 13 on March 2, 2026.
F2 The Reporting Person is the trustee of the Mathers Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest.